MAPK3 and gastric cancer: NUGC3 are wild-type for KRAS, BRAF and PI3KCA. Notably, IGF-1 stimulated phosphorylation of ERK1 and ERK2 in KRAS-activated and BRAF-impaired gastric cancer cells.